buyWeak
Connealy Pamela Ann bought $174k of PYXS
CFO & COO at Pyxis Oncology, Inc.. 88,850 shares at an average of $1.96, traded Nov 26, 2024, filed Nov 27, 2024.
Conviction score
36Value
$174k
88,850 shares
Holdings after
1,199,143
+8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-131606, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | POpen-market purchase Common Stockindirect: By Trust | +5,450 | $2.00 | $11k | 1,115,743 | Nov 27, 2024 |
| Nov 26, 2024 | POpen-market purchase Common Stockindirect: By Spouse | +83,400 | $1.96 | $163k | 1,199,143 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.